Hydralazine
Apresoline (hydralazine) is a small molecule pharmaceutical. Hydralazine was first approved as Apresoline on 1982-01-01. It is used to treat heart failure, malignant hypertension, and pulmonary hypertension in the USA.
Trade Name | Apresoline |
---|---|
Common Name | Hydralazine |
Indication | heart failure, malignant hypertension, pulmonary hypertension |
Drug Class | Antihypertensives (hydrazine-phthalazines) |